In vitro diagnostic DNA blood kit, 11/16
November 2016—U.K.-based Arcis Biotechnology launched its Arcis DNA Blood Kit (IVD) for preparation of DNA from blood using a novel three-minute, two-step system.
Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Posters on POC assays, 10/16
October 2016—ET Healthcare presented two posters at the meeting. Data from the abstract “A whole blood high-sensitivity cardiac troponin assay for POCT” showed that the Pylon cTnl assay met the definition of a fourth-generation high-sensitivity cardiac troponin I assay, with less than 10 percent CV at the 99th percentile and detection in greater than 95 percent of the reference population.
eLearning interface, 10/16
October 2016—Telcor’s QML eLearning interface performs tasks vital to managing point-of-care-testing operators while storing recertification data, such as competency and samples performed together in the company’s QML software for CAP/CMS/JCAHO inspections.
Mass spectrometry medical devices, 10/16
October 2016—Waters Corp. showcased its newest IVD medical device for clinical laboratories, the Acquity UPLC I-Class/Xevo TQ-S micro IVD system. The Xevo TQ-XS is a high-performance tandem quadrupole instrument that aims to expand the scope of ultimate sensitivity analysis.
High-volume platforms, inventory solutions, 10/16
October 2016—Roche launched its presence by featuring several next-generation diagnostic testing platforms and a virtual reality experience that was designed to give attendees an “under the hood” look at a lab of the future and a concept Roche calls the “Roche connected lab.”
Transfusion medicine instrument, predictive technology, 10/16
October 2016—Products on display in Ortho Clinical’s booth included the company’s flagship Integrated Clinical Chemistry and Immunodiagnostic Systems and the Nephrocheck Test. The Ortho Vision Max transfusion medicine instrument (shown below), which is pending 510(k) clearance, was highlighted as well.
Bulk sorter configuration for frozen specimens, 10/16
October 2016—Yaskawa Motoman’s AutoSorter 2000BB bulk sorter has a new configuration available that can maintain frozen specimens in a -20°C environment during the sorting process. The high-speed bulk sorter for high-volume commercial laboratories provides maximum specimen throughput at up to 2,000 tubes per hour.
Ultraprotective vials, 10/16
October 2016—Wheaton launched its DualFusion Vial, which combines properties of plastic and glass into one container. Using plasma enhanced chemical vapor deposition (PECVD) technology, an organosilicate protective layer is fused with a silica-like (SiO2 barrier) layer that is fused to a cyclic olefin polymer (COP) shell to form a robust, covalently bonded material.
Tests for M. genitalium, 10/16
October 2016—SpeeDx Pty, Ltd., featured its PlexPCR for the detection of infectious disease pathogens and the ResistancePlus multiplex qPCR test for the detection of Mycoplasma genitalium and antimicrobial resistance markers.
Streck signs distribution agreement, 10/16
October 2016—Streck and Diesse Diagnostica Senese S.p.A., an Italian manufacturer of in vitro diagnostic systems, are introducing the Diesse Mini-Cube, an automated instrument for erythrocyte sedimentation rate testing in EDTA tubes. Streck will be the exclusive distributor of the Mini-Cube in the United States and Canada.